drugset
drugset / Trial / NCT05191563

A Study to Compare the Pharmacokinetics, Safety and Tolerability Between Fixed-Dose Combination of HCP1904 and Co-Administration of RLD2001-2 and RLD2006 Tablets in Healthy Subjects.

NCT05191563 ↗

Phase 1 Completed 56 enrolled Hanmi Pharmaceutical Company Limited
RandomizedCrossoverOpen-labelTreatment

Summary

An Open-Label, Randomized, Single-Dose Crossover Study to Compare the Pharmacokinetics, Safety and Tolerability Between Fixed-Dose Combination of HCP1904 and Co-Administration of RLD2001-2 and RLD2006 Tablets in Healthy Subjects

Timeline

Start
2021-07-31
Primary completion
2021-09-12
Completion
2021-09-12

Drugs

EvaluationDrugModalityDoseRoute
Subject HCP1904-1 Unknown — —
Subject RLD2001-2 Unknown — —
Subject RLD2006 Unknown — —

Indications

No indication recorded.